In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 18-824V

(not to be published)

* * * * * * * * * * * * * * * * * * * * * * * * *

MARY LIGOURI,

 Petitioner,

v.

SECRETARY OF HEALTH AND

HUMAN SERVICES,

 Respondent.

* * * * * * * * * * * * * * * * * * * * * * * * *

*

*

*

*

*

*

*

*

*

*

*

*

*

*

*

*

*

Filed: April 15, 2021

Ruling on Entitlement; Influenza (“Flu”)

Vaccine; Guillain-Barré syndrome

Andrew Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for Petitioner

Sarah Duncan, U.S. Department of Justice, Washington, DC, for Respondent

RULING ON ENTITLEMENT1

On June 12, 2018, Mary Ligouri (“Petitioner”) filed a petition, seeking compensation under 

the National Vaccine Injury Compensation Program (“the Vaccine Program”).2 Pet., ECF No. 1. 

Petitioner alleges that she developed Guillain-Barré syndrome as a result of the influenza (“flu”)

vaccination she received on January 3, 2018. Pet. at 1-3, ECF No. 1. 

1 Although this Ruling has been formally designated “not to be published,” it will nevertheless be posted 

on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. § 

3501 (2012). This means the Ruling will be available to anyone with access to the internet. As provided 

by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Ruling’s inclusion of certain 

kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days 

within which to request redaction “of any information furnished by that party: (1) that is a trade secret or 

commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or 

similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine 

Rule 18(b). Otherwise, the Ruling in its present form will be available. Id.

2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. 

No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter 

“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the 

pertinent subparagraph of 42 U.S.C. § 300aa.
On April 20, 2020, Petitioner filed an expert report from Dr. Peter-Brian Andersson, a 

board-certified neurologist, which addressed Petitioner’s symptoms prior to her January 3, 2018 

vaccination. Ex. 17. 

On October 2, 2020, in an Amended Rule 4(c) Report, Respondent stated his position is 

that “petitioner has now satisfied the criteria set forth in the Vaccine Injury Table and QAI, which 

afford[s] petitioner a presumption of causation if the diagnosis of GBS is sound; the onset of GBS 

occurs between three and forty-two days after a seasonal flu vaccination; and, there is no identified 

more likely alternative diagnosis.” Am. Resp’t’s Rep. at 2-3; see also 42 C.F.R. § 

100.3(a)(XIV)(D), (c)(15). Respondent requested a ruling on the record regarding Petitioner’s 

entitlement to compensation.

In view of Respondent’s position and the evidence of record, I find that the Petitioner 

is entitled to compensation. 

IT IS SO ORDERED. 

s/ Katherine E. Oler

Katherine E. Oler

Special Master